The iLite® RANKL Assay Ready Cells can be used for the quantification of RANKL activity, RANKL inhibitor activity or immunogenicity studies and determination of neutralizing antibody response against RANKL inhibitors in test samples, including human serum.
iLite® RANKL Assay Ready Cells are human HEK293[1] cells (ATCC# CRL-1573) which have been genetically engineered and optimized to be responsive to human soluble RANK Ligand (RANKL), resulting in a proportional expression of Firefly Luciferase. Normalization of cell counts, and serum matrix effects is obtained by a second reporter gene, a Renilla Luciferase reporter gene construct, under control of a constitutive promotor. [1] The HEK-293 cell line has been used under a license obtained from AdVec Inc. FOR RESEARCH USE ONLY.